MIRM earnings: next report 2026-07-30, real EPS beat/miss history, analyst consensus Buy, P/E -8.41. Updated 2026-07-23.
Mirum Pharmaceuticals (MIRM) Research Hub
Mirum Pharmaceuticals (MIRM) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 98.22 USD (-0.08%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -8.41, market cap 5.75B. This hub links to the full technical, earnings and options research available for MIRM.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 98.22 USD (-0.08%) |
| 52-week range | 88.88 USD – 130 USD |
| Trend regime | Range |
| 14-day RSI | 44.4 (Bearish) |
| Trailing P/E | -8.41 |
| Market cap | 5.75B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-30 |
Available research for MIRM
Covered Call on MIRM: how it works, illustrative setup around the real 98.22 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MIRM: how it works, illustrative setup around the real 98.22 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MIRM: how it works, illustrative setup around the real 98.22 USD price, max profit/loss, breakeven and when to use it. Educational.
MIRM technical analysis: range, last 98.22 USD, RSI 44.4, 52w range 88.88 USD–130 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is MIRM in?
Mirum Pharmaceuticals (MIRM) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is MIRM in an uptrend or downtrend?
As of 2026-09-11, MIRM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MIRM's trailing P/E ratio?
MIRM's trailing P/E is -8.41, with a market cap of 5.75B. See the earnings research page for full valuation detail.
When does MIRM next report earnings?
MIRM is next scheduled to report earnings on 2026-07-30, with a consensus EPS estimate of -0.72792 USD.